European Union to give the green light to new Covid-19 vaccine contract
Any vaccine needs to be approved by the European Medicines Agency for safety and efficiency before it hits the market
 "Ursula von der Leyen, EU chief, European Commission, eu")
European Commission chief Ursula von der Leyen. Photo: Shutterstock
The European Union (EU) will give the green light to a new vaccine contract in its bid to fight the COVID-19 pandemic, said European Commission President Ursula von der Leyen.
Through the purchase of up to 160 million doses of vaccines produced by American pharmaceutical company Moderna, the EU will be able to enrich its COVID-19 vaccine portfolio, Xinhua news agency reported on Wednesday.
"Only a safe and effective vaccine will provide a lasting and sustainable solution to this pandemic," noted von der Leyen on Tuesday.
It needs to be approved by the European Medicines Agency for safety and efficiency before any vaccine is allowed to hit the European market.
Apart from Moderna, the EU's current vaccine portfolio includes purchase agreements with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer and CureVac.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 25 2020 | 1:58 PM IST